Skip to Content

MYLAN 6727 MYLAN 6727 (Zonisamide 100 mg)

Pill with imprint MYLAN 6727 MYLAN 6727 is Purple / Blue, Capsule-shape and has been identified as Zonisamide 100 mg. It is supplied by Mylan Pharmaceuticals Inc..

Zonisamide is used in the treatment of migraine prevention; seizures; parkinsonian tremor; benign essential tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 6727 MYLAN 6727

Zonisamide 100 mg MYLAN 6727 MYLAN 6727
Zonisamide 100 mg MYLAN 6727 MYLAN 6727 Front
Zonisamide 100 mg MYLAN 6727 MYLAN 6727 Back
Zonisamide 100 mg MYLAN 6727 MYLAN 6727


MYLAN 6727 MYLAN 6727
100 mg
Purple / Blue
18.00 mm
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
lactose anhydrous
ferrosoferric oxide
silicon dioxide
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
microcrystalline cellulose
propylene glycol
sodium lauryl sulfate
titanium dioxide
FD&C Red No. 3
magnesium stearate
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0768 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.